AI VIVO is Drug Discovery in United Kingdom that focus on life cycle management business. Founded in 2017. They cover business area such as developer, an AI-base pharmacology platform, drug discovery, life cycle management, data generation, proprietary disease, perturbation database, therapeutic repositioning, combination prediction, Machine Learning, AI algorithms, biological hypothesis, datum, medical insight, novel discovery.
2017
( 7 years old in 2024 )
Life Cycle Management
-
Unit 25, Cambridge Science Park
The Bio-Innovation Centre
Cambridge CB4 0FW
England, United Kingdom
Private
developeran AI-base pharmacology platformdrug discoverylife cycle managementdata generationproprietary diseaseperturbation databasetherapeutic repositioningcombination predictionMachine LearningAI algorithmsbiological hypothesisdatummedical insightnovel discovery
* We use standard office opening hours in near AI VIVO's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
AI VIVO is Drug Discovery business from United Kingdom that founded in 2017 (7 years old in 2024), AI VIVO business is focusing on Life Cycle Management.
AI VIVO headquarter office and corporate office address is located in Unit 25, Cambridge Science Park The Bio-Innovation Centre Cambridge CB4 0FW England, United Kingdom.
AI VIVO was founded in United Kingdom.
In 2024, AI VIVO is currently focus on life cycle management sector.
Above is snippet of Google Trends for "life cycle management" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with AI VIVO, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
